Increased prevalence of gestational diabetes mellitus in in vitro fertilization pregnancies inadvertently conceived during treatment with long-acting triptorelin acetate

Amit Mayer, Eitan Lunenfeld, Arnon Wiznitzer, Iris Har-Vardi, Yacov Bentov, Eliahu Levitas*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Thirty-five pregnancies were inadvertently conceived during the midluteal application of the long-acting gonadotropin-releasing hormone agonist triptorelin acetate before ovarian stimulation for in vitro fertilization. Most of the conceptions occurred before the first or second IVF trial, and were associated with a significantly increased tendency to develop gestational diabetes. No increase in pregnancy wastage or appearance of congenital malformations occurred.

Original languageEnglish
Pages (from-to)789-792
Number of pages4
JournalFertility and Sterility
Volume84
Issue number3
DOIs
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'Increased prevalence of gestational diabetes mellitus in in vitro fertilization pregnancies inadvertently conceived during treatment with long-acting triptorelin acetate'. Together they form a unique fingerprint.

Cite this